NDC 51662-1302

LIDOCAINE HCI AND DEXTROSE

Lidocaine Hci And Dextrose

LIDOCAINE HCI AND DEXTROSE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Lidocaine Hydrochloride.

• Product ID: 51662-1302_861bbf1e-04c6-a892-e053-2a91aa0a678a
• NDC: 51662-1302
• Product Type: Human Prescription Drug
• Proprietary Name: LIDOCAINE HCI AND DEXTROSE
• Generic Name: Lidocaine Hci And Dextrose
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-04-09
• Marketing Category: NDA / NDA
• Application Number: NDA018461
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: LIDOCAINE HYDROCHLORIDE
• Active Ingredient Strength: 4 mg/mL
• Pharm Classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1302-1

500 mL in 1 BAG (51662-1302-1)

• Marketing Start Date: 2019-04-09
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1302-1 [51662130201]

LIDOCAINE HCI AND DEXTROSE INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA018461
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-04-09

Drug Details

Active Ingredients

Ingredient	Strength
LIDOCAINE HYDROCHLORIDE	4 mg/mL

Pharmacological Class

• Amide Local Anesthetic [EPC]
• Amides [CS]
• Antiarrhythmic [EPC]
• Local Anesthesia [PE]

NDC Crossover Matching brand name "LIDOCAINE HCI AND DEXTROSE" or generic name "Lidocaine Hci And Dextrose"

NDC	Brand Name	Generic Name
51662-1302	LIDOCAINE HCI AND DEXTROSE	LIDOCAINE HCI AND DEXTROSE
51662-1565	LIDOCAINE HCI AND DEXTROSE	LIDOCAINE HCI AND DEXTROSE